24 reports

Anti-Procollagen type I C-terminal propeptide (human, PICP) Mouse monoclonal antibody ##.

  • Diabetes Care
  • North America
  • World
  • Abbott Laboratories, Inc.
  • Danaher Corporation

Simulect® (basiliximab) is a chimeric (murine/ human) monoclonal antibody Zortress/ Certican (everolimus) is an oral inhibitor of the mTOR pathway.

  • Diabetes Care
  • North America
  • World
  • Market Size
  • Pfizer Inc.

The company provides biosimilars comprising recombinant human insulin, insulin glargine, insulin lispro, insulin aspart, and monoclonal antibodies and other biologics.

  • Diabetes Care
  • World
  • Forecast
  • Market Size
  • Novo Nordisk Group

BD Life Sciences involve in the production of research and clinical tools that facilitate the study of cells, for instance company fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for Moreover, company i

  • Cell Therapy
  • Diabetes Care
  • North America
  • World
  • Becton Property Group

In 2016, Roche signed a license agreement with Eleven Biotherapeutics, Cambridge, US, for its novel anti-IL-## monoclonal antibody, which is positioned to be a first-in-class treatment for wet age-related macular degeneration and diabetic macular oedema. cmlxii Recent News And Devel

  • Diabetes Care
  • World
  • Forecast
  • Market Size
  • Roche Group

In 2016, Roche signed a license agreement with Eleven Biotherapeutics, Cambridge, US, for its novel anti-IL-## monoclonal antibody, which is positioned to be a first-in-class treatment for wet age-related macular degeneration and diabetic macular oedema. cmlxii Recent News And Devel

  • Diabetes Care
  • World
  • Forecast
  • Market Size
  • Roche Group

TABLE ##. ##.

  • Diabetes Care
  • World
  • Forecast
  • Market Size
  • Insulet Corporation

The company also manufactures a diverse range of research reagents in the areas of PDZ proteomics and monoclonal antibodies.

  • Diabetes Care
  • North America
  • United States
  • Alere Inc.
  • Danaher Corporation

Infusions include chemotherapy, monoclonal antibodies infusions, pamidronate, gammaglobulin, blood product transfusion, hemodialysis, and intravenous enzyme therapies.

  • Diabetes Care
  • World
  • Hospira, Inc.
  • Medtronic, Inc.
  • Pfizer Inc.

NicAlert is an immunochromatographic assay that uses monoclonal antibody-coated gold particles and a series of avidity traps that allow quantification.

  • Diabetes Care
  • World
  • Alere Inc.
  • Beckman Coulter, Inc.
  • Roche Group

On August ##, 2018, Roche launched monoclonal antibody atezolizumab under the brand name Tecentriq in India for the treatment of lung and bladder cancer.

  • Diabetes Care
  • Medical Device
  • United States
  • World
  • Insulet Corporation
  • Insulin Delivery Devices Companies and Product Overview

SAR##, a T-cell engaging multi-specific monoclonal antibody, entered Phase ## for the treatment of leukemia.

  • Clinical Trial
  • Diabetes Care
  • Insulin Delivery
  • Pharmaceutical
  • Pfizer Inc.

SAR##, a T-cell engaging multi-specific monoclonal antibody, entered Phase ## for the treatment of leukemia.

  • Clinical Trial
  • Diabetes
  • Diabetes Care
  • Diabetes Monitoring
  • Medical Device

The company provides biosimilars comprising recombinant human insulin, insulin glargine, insulin lispro, insulin aspart, and monoclonal antibodies and other biologics.

  • Diabetes Care
  • Europe
  • Forecast
  • Market Size
  • Novo Nordisk Group

The company provides biosimilars comprising recombinant human insulin, insulin glargine, insulin lispro, insulin aspart, and monoclonal antibodies and other biologics.

  • Diabetes Care
  • APAC
  • Forecast
  • Market Size
  • Novo Nordisk Group

Tanezumab is a humanized monoclonal antibody that is part of an investigational class of non-opioid pain medications known as nerve growth factor inhibitors.

  • Clinical Trial
  • Diabetes Care
  • Insulin Delivery
  • Therapy
  • Roche Group

Following the approval to proceed with the clinical trials for ZKAB##, an anti PD-L## monoclonal antibody, in January 2018.

  • Clinical Trial
  • Diabetes Care
  • Patient Monitoring
  • United States
  • Medtronic, Inc.

The company provides biosimilars comprising recombinant human insulin, insulin glargine, insulin lispro, insulin aspart, and monoclonal antibodies and other biologics.

  • Diabetes Care
  • North America
  • Forecast
  • Market Size
  • Novo Nordisk Group

Cemiplimab is an investigational human, monoclonal antibody targeting PD-##, being jointly developed by Sanofi and Regeneron.

  • Clinical Trial
  • Diabetes Care
  • Insulin Delivery
  • Pharmaceutical
  • Sanofi S.A.

ALZUMAb™, a novel biologic developed by Biocon, is the world s first anti-CD## monoclonal antibody introduced in India for Psoriasis.

  • Diabetes Care
  • Insulin Delivery
  • India
  • South Asia
  • Biocon Limited

The Aggregate gross margin ratio also reflected the investment in monoclonal antibodies production.

  • Diabetes Care
  • Medical Device
  • France
  • Western Europe
  • Sanofi S.A.

Benralizumab is an eosinophil-depleting monoclonal antibody and AstraZeneca s first respiratory biologic medicine.

  • Diabetes Care
  • Medical Device
  • Northern Europe
  • United Kingdom
  • AstraZeneca PLC

Inflectra is now the first and only biosimilar monoclonal antibody therapy to be approved in the U. S.

  • Diabetes
  • Diabetes Care
  • Diabetes Monitoring
  • Insulin Delivery
  • Therapy

The Aggregate gross margin ratio also reflected the investment in monoclonal antibodies production.

  • Diabetes Care
  • Insulin Delivery
  • United States
  • Demand
  • Sanofi S.A.